The therapeutic potential of neuropeptide Y in central nervous system disorders with special reference to pain and sympathetically maintained pain

Author： Cougnon N. Hudspith M. Munglani R.

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.6, Iss.6, 1997-06, pp. : 759-770

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The Putative Neuroprotective Role of Neuropeptide Y in the Central Nervous System

Current Drug Targets-CNS & Neurological Disorders, Vol. 4, Iss. 4, 2005-08 ,pp. : 331-347

Bentham Science Publishers

Access to resources Recommend Favorite

The Insulin-like Growth Factor-1 Axis and its Potential as a Therapeutic Target in Central Nervous System (CNS) Disorders

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 9, Iss. 2, 2009-06 ,pp. : 95-109

Bentham Science Publishers

Access to resources Recommend Favorite

Notch Signaling in the Central Nervous System with Special Reference to its Expression in Microglia

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 12, Iss. 6, 2013-01 ,pp. : 807-814

Bentham Science Publishers

Access to resources Recommend Favorite

Central functions of neuropeptide Y in mood and anxiety disorders

By Wu Gang Feder Adriana Wegener Gregers Bailey Christopher Saxena Shireen Charney Dennis Mathé Aleksander A

Expert Opinion on Therapeutic Targets, Vol. 15, Iss. 11, 2011-11 ,pp. : 1317-1331

Informa Healthcare

Access to resources Recommend Favorite

Trigonelline: A Plant Alkaloid with Therapeutic Potential for Diabetes and Central Nervous System Disease

Current Medicinal Chemistry, Vol. 19, Iss. 21, 2012-07 ,pp. : 3523-3531

Bentham Science Publishers

Access to resources Recommend Favorite